Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India

about

Adverse drug reaction monitoring in patients on antiretroviral therapy in a tertiary care hospital in Eastern India.

P2860

Q42375088-C74C26D9-BBB3-421D-96F7-86B53D30B2C5

P2860

Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India

Item

http://www.wikidata.org/entity/Q36876753

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India

@en

type

Item

label

Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India

@en

prefLabel

Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India

@en

P1476

Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India

@en

P2093

Beena Thomas

http://www.w3.org/2001/XMLSchema#string

Nomita Chandhiok

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Prevention of HIV-1 infection with early antiretroviral therapy

Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Preexposure prophylaxis for HIV infection among African women

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

Predicting product adherence in a topical microbicide safety trial in Pune, India.

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

P304

125-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4103/0971-5916.180194

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth Mayer

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27121509

http://www.w3.org/2001/XMLSchema#string

P932

4859120

http://www.w3.org/2001/XMLSchema#string

Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India

about

P2860

P2860

Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932